Fentanyl adulterated or associated with xylazine implementation report.
| Corporate Authors: | , , , , , , , |
|---|---|
| Format: | Government Document Serial |
| Language: | English |
| Published: |
Washington, D.C. :
The White House, Executive Office of the President, Office of National Drug Control Policy,
2024-
|
| Subjects: | |
| Online Access: | Available from GovInfo Available from ONDCP |
| Published: | Began with: June 2024. |
|---|---|
| Item Description: | In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP). United States federal government branch: Executive branch. Access ID (GovInfo): CMR-PREX26-00188641. Legal authority: 21 U.S.C. ยง 1708. United States Congress receiving chamber(s): United States House of Representatives and Senate. United States Congress receiving committee(s): Committee on Appropriations, Committee on Oversight and Accountability, Committee on Energy and Commerce, Committee on the Judiciary, Committee on Appropriations, Committee on Health, Education, Labor, and Pensions, Committee on the Judiciary. GPO Cataloging Record Distribution Program (CRDP). |
| Physical Description: | 1 online resource (volumes) |
| Publication Frequency: | Annual |